Lu_2022_Br.J.Clin.Pharmacol_88_2946

Reference

Title : A double-blind, randomized, placebo and positive-controlled study in healthy volunteers to evaluate pharmacokinetic and pharmacodynamic properties of multiple oral doses of cetagliptin - Lu_2022_Br.J.Clin.Pharmacol_88_2946
Author(s) : Lu J , Wang L , Zhou S , Zhou C , Xie L , Chen J , Tang D , Tian X , Xie D , Ding J , Wang T , Yu Q , Shao F
Ref : British Journal of Clinical Pharmacology , 88 :2946 , 2022
Abstract : Lu_2022_Br.J.Clin.Pharmacol_88_2946
ESTHER : Lu_2022_Br.J.Clin.Pharmacol_88_2946
PubMedSearch : Lu_2022_Br.J.Clin.Pharmacol_88_2946
PubMedID: 34965609

Related information

Citations formats

Lu J, Wang L, Zhou S, Zhou C, Xie L, Chen J, Tang D, Tian X, Xie D, Ding J, Wang T, Yu Q, Shao F (2022)
A double-blind, randomized, placebo and positive-controlled study in healthy volunteers to evaluate pharmacokinetic and pharmacodynamic properties of multiple oral doses of cetagliptin
British Journal of Clinical Pharmacology 88 :2946

Lu J, Wang L, Zhou S, Zhou C, Xie L, Chen J, Tang D, Tian X, Xie D, Ding J, Wang T, Yu Q, Shao F (2022)
British Journal of Clinical Pharmacology 88 :2946